Innate immune system pattern-recognition and inflammatory pathways (PRR pathways)

The innate immune system pattern-recognition and inflammatory pathways comprise a diverse group of germline-encoded receptors and signaling cascades that serve as the first line of host defense [Nature Immunology, 2010]. These pathways are activated by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), which detect conserved microbial structures known as pathogen-associated molecular patterns (PAMPs) or endogenous signals of cell stress called danger-associated molecular patterns (DAMPs) [Cell, 2010]. Activation of these receptors triggers complex intracellular signaling involving adapter proteins like MyD88 and kinases like IRAKs, ultimately leading to the nuclear translocation of transcription factors such as NF-κB and IRFs [PubMed: 20303872]. This results in the robust production of pro-inflammatory cytokines (e.g., TNF, IL-1β, IL-6) and type I interferons, which are essential for pathogen clearance but can cause tissue damage if left unchecked [Blood, 2011]. Chronic or inappropriate activation of these pathways is central to the pathogenesis of various conditions, including rheumatoid arthritis, atherosclerosis, and metabolic syndrome [Nature Reviews Drug Discovery, 2019]. Pharmacological intervention typically targets specific nodes within these pathways, such as the NLRP3 inflammasome or specific TLRs, to treat inflammatory and autoimmune disorders [Journal of Clinical Investigation, 2015].

Other names

Pattern recognition receptor signalingInnate immune signalingPRR-mediated inflammatory pathwaysPAMP/DAMP sensing pathwaysInnate immune pathways

Drugs targeting these pathways function by antagonizing specific pattern recognition receptors, inhibiting downstream signaling kinases (e.g., JAK, IRAK), or neutralizing the resulting inflammatory cytokines to suppress pathological immune activation.